CWM
ABBV icon

Chemistry Wealth Management’s AbbVie ABBV Stock Holding History

Chemistry Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
7,492
+760
+11% +$164K 0.3% 55
2026
Q1 		$1.46M Sell
6,732
-1,111
-14% -$246K 0.26% 59
2025
Q4 		$1.79M Sell
7,843
-1,430
-15% -$326K 0.34% 48
2025
Q3 		$2.15M Hold
9,273
– – 0.41% 39
2025
Q2 		$1.72M Sell
9,273
-97
-1% -$18K 0.37% 45
2025
Q1 		$1.96M Buy
9,370
+454
+5% +$88.3K 0.46% 38
2024
Q4 		$1.58M Buy
8,916
+282
+3% +$51.8K 0.37% 42
2024
Q3 		$1.71M Sell
8,634
-6,525
-43% -$1.22M 0.4% 41
2024
Q2 		$2.6M Sell
15,159
-5,301
-26% -$878K 0.67% 28
2024
Q1 		$3.73M Sell
20,460
-240
-1% -$41.4K 1% 20
2023
Q4 		$3.21M Sell
20,700
-646
-3% -$94.2K 0.97% 22
2023
Q3 		$3.18M Sell
21,346
-1,233
-5% -$181K 1.05% 19
2023
Q2 		$3.04M Buy
22,579
+1,276
+6% +$187K 0.99% 20
2023
Q1 		$3.4M Sell
21,303
-460
-2% -$70.3K 1.18% 16
2022
Q4 		$3.52M Sell
21,763
-610
-3% -$93.5K 1.37% 14
2022
Q3 		$3M Sell
22,373
-1,341
-6% -$192K 1.19% 17
2022
Q2 		$3.63M Sell
23,714
-1,583
-6% -$242K 1.39% 12
2022
Q1 		$4.1M Buy
+25,297
New +$3.67M 1.41% 14

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Chemistry Wealth Management's ABBV Position: Q2 2026 in Review

Chemistry Wealth Management increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $164K and bringing the position to 7,492 shares worth $1.89M. The position accounts for 0.3% of the portfolio, ranked #55.

Chemistry Wealth Management first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.1M in Q1 2022. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Chemistry Wealth Management held 7,492 shares of AbbVie worth $1.89M as of Q2 2026.
  • Chemistry Wealth Management bought 760 AbbVie shares in Q2 2026, an estimated $164K.
  • AbbVie made up 0.3% of Chemistry Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Chemistry Wealth Management first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • Chemistry Wealth Management's AbbVie position peaked at $4.1M in Q1 2022.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.